Roche Venture Fund
Basel, Basel-Stadtventurefund.roche.com
Overview
The Roche Venture Fund is the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients . They invest in life science companies aiming to create value by fostering innovation, guiding successful businesses and generating financial return to Roche . The fund focuses on investments in early-stage life science companies operating in the pharmaceuticals, diagnostics and digital health sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mission Therapeutics | Oct 2025 | Series D Extension | Lead |
| SpliceBio | Jun 2025 | Series B | Co-investor |
| Mission Therapeutics | Mar 2024 | Series D | Lead |
| COUR Pharmaceuticals | Jan 2024 | Series A | - |
| GlycoEra | Jan 2024 | Series A Extension | Co-investor |
Key People
Nardjess Nawel Laroussi
Patient Journey Partner
Sami FILALI
Patient Journey Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
